VAERS reports by lot

GSK Varicella/Shingles lot BY2Y4: VAERS reports

45 VAERS reports list lot BY2Y4 as a GSK Varicella/Shingles vaccine, received between 2019-08-11 and 2020-09-10. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
45
Reports
0%
Marked serious
0
With a death outcome
12
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
General / Systemic (non-local)5531%
Injection-site / Local reaction3821%
Neurological2112%
Musculoskeletal1810%
Allergic / Anaphylactic127%
Gastrointestinal116%
Dermatological (non-injection-site)106%
Cardiac / Cardiovascular84%
Respiratory21%
Thrombotic / Hematological11%
Autoimmune / Immune-mediated11%
Psychiatric / Neuropsychiatric11%

Where reports came from

U.S. state of the reporter, where given (top 12).

Illinois6
Indiana5
Ohio3
Michigan3
Maryland3
Virginia2
Massachusetts2
Maine2
New Jersey2
North Carolina2
Connecticut2
New York2

Reports by month received

2019-085
2019-0911
2019-103
2019-115
2019-1210
2020-013
2020-021
2020-031
2020-063
2020-071
2020-081
2020-091

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.